Amgen Inc.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40013586

Informations générales

Localisation

United States of America

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

22/09/2022

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Description complète des objectifs

Amgen commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2027 from a 2019 base year. Amgen also commits to increase annual sourcing of renewable electricity from 29% in 2019 to 100% by 2027, to continue annually sourcing of 100% renewable electricity through 2030. Amgen further commits that 73% of its suppliers by spend covering upstream purchased goods and services and capital goods will have science- based targets by 2027.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

62QBXGPJ34PQ72Z12S66

Source : Science Based Targets initiative | Données publiques